Abstract
We have identified several ligands with high binding affinities to the dopamine D3 receptor and excellent selectivity over the D2 and D1 receptors. CJ-1639 (17) binds to the D3 receptor with a K i value of 0.50 nM and displays a selectivity of >5000 times over D2 and D1 receptors in binding assays using dopamine receptors expressed in the native rat brain tissues. CJ-1639 binds to human D3 receptor with a K i value of 3.61 nM and displays over >1000-fold selectivity over human D1 and D2 receptors. CJ-1639 is active at 0.01 mg/kg at the dopamine D3 receptor in the rat and only starts to show a modest D2 activity at doses as high as 10 mg/kg. CJ-1639 is the most potent and selective D3 full agonist reported to date.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 620-625 |
| Number of pages | 6 |
| Journal | ACS Medicinal Chemistry Letters |
| Volume | 2 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 11 2011 |
| Externally published | Yes |
Keywords
- Dopamine receptors
- agonists
- drug abuse
- ligands
ASJC Scopus subject areas
- Drug Discovery
- Biochemistry
- Organic Chemistry